(Q84435201)
Statements
Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk (English)
Toshitaka Nakamura
Toshitsugu Sugimoto
Tetsuo Nakano
Hideaki Kishimoto
Masako Ito
Masao Fukunaga
Hiroshi Hagino
Teruki Sone
Hideki Yoshikawa
Yoshiki Nishizawa
Takuo Fujita
Masataka Shiraki